Henry Schein Inc   (HSIC)
Other Ticker:  
Price: $66.6600 $-0.75 -1.113%
Day's High: $67.53 Week Perf: -3.95 %
Day's Low: $ 66.26 30 Day Perf: 0.77 %
Volume (M): 1,393 52 Wk High: $ 89.72
Volume (M$): $ 92,857 52 Wk Avg: $77.55
Open: $66.92 52 Wk Low: $60.01

 Market Capitalization (Millions $) 8,762
 Shares Outstanding (Millions) 131
 Employees 21,600
 Revenues (TTM) (Millions $) 12,693
 Net Income (TTM) (Millions $) 470
 Cash Flow (TTM) (Millions $) 44
 Capital Exp. (TTM) (Millions $) 137

Henry Schein Inc
Henry Schein Inc. is a multinational distributor of medical, dental, and veterinary supplies. It was founded in 1932 by a pharmacist named Henry Schein, who opened a small drug store in Queens, New York. Over the years, the company has grown into a global entity with more than 20,000 employees and operations in over 30 countries.

The company's main headquarters are located in Melville, New York, where they have more than5 million square feet of office space. The company is publicly traded on the NASDAQ stock exchange and has a market capitalization of over $16 billion.

The company's customer base includes a wide range of healthcare providers, including hospitals, dental practices, medical clinics, and veterinary clinics. It offers a broad range of products and services, including medical supplies, pharmaceuticals, and equipment, dental supplies and equipment, veterinary supplies and equipment, and IT solutions.

In addition to providing products and services, Henry Schein is also actively involved in philanthropic initiatives. The company has a long-standing commitment to corporate social responsibility and is dedicated to advancing access to healthcare and promoting education and economic development in underserved communities. This commitment is evidenced by its various initiatives, including the Henry Schein Cares Foundation, which provides financial and product donations to help increase access to healthcare services around the world.

Overall, Henry Schein Inc. is a leading player in the healthcare distribution industry, with a reputation for quality products, exceptional customer service, and a commitment to giving back to communities in need.

   Company Address: 135 Duryea Road Melville 11747 NY
   Company Phone Number: 843-5500   Stock Exchange / Ticker: NASDAQ HSIC
   HSIC is expected to report next financial results on February 20, 2024.


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Intelligent Bio Solutions Inc

Shortfall bigger than a year ago at INBS all along the financial time-frame closing September 30 2023

company announced very strong Revenue rise of 155.716 % year on year to $0.80 million in the financial span ending September 30 2023, but Losses have swelled at $-1.04. Intelligent Bio Solutions Inc s' top-line grew more compared to the the revenue at virtually all of the Medical Equipment and Supplies sector peers, in the first quarter of 2024 the most entities in Medical Equipment and Supplies industries experienced an average top-line rise of 5.93% from the first quarter of 2023.

Interpace Biosciences Inc

Regardless of the Topline improvement, The company lost money, in the fiscal third quarter of 2023

Revenue improvement of 9.342 % year on year to $8.95 million in the fiscal span ending September 30 2023 were not enough to reach break even, the company posted loss per share of $-0.14. PDIIs' revenue, improvement in the third quarter of 2023 measures positively to its Medical Equipment and Supplies sector peers, which had overall 5.93 % business improvement during the matching time thus far.

Co Diagnostics Inc

Shortfall higher than a year before at the CODX in financial span closing September 30 2023

CODX declared disastrous most recent fiscal period, where Revenue faded by -51.769 % to $2.46 million and net deficit per share has expanded to $-0.20, from the similar quarter a year before.

Legacy Ventures International Inc

Legacy Ventures International Inc's Exceptional Financial Results in the Medical Equipment and Supplies Industry Indicate Strong Progress

As the July to September 30, 2023 reporting cycle resumes, various corporations, including Legacy Ventures International Inc in the Medical Equipment and Supplies sector, have announced their financial results. In a surprising turn of events, Legacy Ventures International Inc managed to conduct business more economically compared to the previous fiscal quarter, indicating positive signs of progress. This article will delve into the implications of these financial results and explore how they may impact the company going forward.
Improved Operating Deficit:
Legacy Ventures International Inc reported an operating deficit of $-0.006744 million for the July to September 30, 2023 three-month period, which is an improvement from the operating deficit of $-0.009667 million in the same period of the previous year. This significant reduction in operating deficit indicates that the company has been successful in implementing cost-saving measures and enhancing operational efficiency.

Vivos Inc

The company announced sturdy revenue rise, in the third quarter of 2023

Vivos Inc, a leading player in the Medical Equipment and Supplies industry, recently announced its financial results for the fiscal third quarter of 2023. Despite a challenging economic landscape, the company showed resilience by reaching break-even, reporting earnings of $0.00 per share. This is the same as the previous year and the preceding reporting season.
In terms of revenue, Vivos Inc showcased a modest 7.692% growth, generating $0.01 million compared to $0.01 million in the same reporting season a year ago. The sequential revenue growth from the preceding reporting season was also 7.692%. This growth outperforms the Medical Equipment and Supplies sector average of 5.93% in the same period, highlighting Vivos Inc's impressive performance in terms of top-line growth.


Henry Schein Inc's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com